Trials / Sponsors / University of Tennessee Cancer Institute
University of Tennessee Cancer Institute
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Temsirolimus as Second-line Therapy in HCC Unresectable or Metastatic Hepatocellular Carcinoma | Phase 2 | 2010-02-01 |
| Terminated | Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Squamous Cell Carcinoma of the Head and Neck | Phase 1 / Phase 2 | 2010-02-01 |
| Unknown | Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery. Breast Cancer | Phase 2 | 2008-10-01 |